Network
General information
| Name | National Heart, Lung, and Blood Institute Cohort Studies |
|---|---|
| Acronym | NHLBI |
| Last update | 01/21/2010 |
Principal investigators
|
Philip Wolf (Dr.)
|
Framingham Heart Study, Boston University |
|
Curt Furberg (Dr.)
|
CHS, Wake Forest University |
|
Barbara Howard (Dr.)
|
Strong Heart Study, Medlantic Research Foundation |
|
Herman Taylor (Dr.)
|
Jackson Heart Study, University of Mississippi Medical Center |
|
Aaron Folsom (Dr.)
|
ARIC, University of Minnesota |
|
Stephen Hulley (Dr.)
|
CARDIA, University of California |
|
Teri Manolio (Dr.)
|
NHLBI |
Contact
|
Kevin Purkiser (Dr.)
|
NHLBI, Building 31, Room 5A52 Bethesda 20892 Phone: 301 592 8573 Email: |
Website
- http://www.nhlbi.nih.gov/
Background
Cardiovascular disease is the leading cause of morbidity and mortality in the US as in most of the world. Risk factors for development of this and related diseases have been and continue to be identified through NHLBI's major cohort studies, but the relationship of disease risk to genetic variation in populations is only beginning to be understood. These well-phenotyped cohorts also include extensive information on environmental modifiers of genetic risk and hold considerable potential for the identification, replication, and interpretation of disease risk related to genes, environment, and their interactions.
Objectives
To identify risk factors for development, progression, and outcomes of heart, lung, blood, and sleep disorders on a population basis.
Member organizations
| Design of the member studies | Cohort |
|---|
Members
- Atherosclerosis Risk in Communities Studies [ARIC]
- Cardiovascular Health Study [CHS]
- Coronary Artery Risk Development in Young Adults Study (CARDIA)
- Framingham Heart Study
- Honolulu Heart Program [HHP]
- Jackson Heart Study [JHS]
- Strong Heart Study
